Literature DB >> 30311827

Effect of baseline brain activity on response to low-frequency rTMS/intensive occupational therapy in poststroke patients with upper limb hemiparesis: a near-infrared spectroscopy study.

Hiroaki Tamashiro1, Shoji Kinoshita2,3, Takatsugu Okamoto1,2, Naoki Urushidani1, Masahiro Abo2.   

Abstract

BACKGROUND: The beneficial effects of the combination therapy of low-frequency repetitive transcranial magnetic stimulation of nonlesional hemisphere and intensive occupational therapy (LF-rTMS/OT) on upper limb hemiparesis have been well established in poststroke patients. However, there is no information on the effect of brain activity on LF-rTMS/OT treatment outcome.
METHOD: A total of 59 poststroke patients with upper limb hemiparesis received 15-day LF-rTMS/OT. Motor function of the affected upper limb was evaluated before and after the treatment. We also conducted functional near-infrared spectroscopy (fNIRS) before the treatment and calculated the laterality index (LI) based on the change in oxy-hemoglobin in the primary sensorimotor cortex and supplementary motor cortex. The correlation between LI before LF-rTMS/OT and observed improvement in upper limb motor function was analyzed.
RESULTS: Motor recovery was significantly more pronounced in patients with unaffected hemisphere dominance in both hemispheres (LI of -1 to 0) than in those with affected hemisphere dominance in the lesional hemisphere (LI of 0 to 1). There was a significant negative correlation between LI and improvement in upper limb motor function. DISCUSSION: The results demonstrated that patients with a shift in brain activity to the noninjured cerebral cortex exhibited better motor recovery following LF-rTMS/OT. The findings suggest that evaluation of brain asymmetry before LF-rTMS/OT with fNIRS can help predict the response to LF-rTMS/OT.

Entities:  

Keywords:  Functional near-infrared spectroscopy; functional brain imaging; occupational therapy; rehabilitation; repetitive transcranial magnetic stimulation

Mesh:

Year:  2018        PMID: 30311827     DOI: 10.1080/00207454.2018.1536053

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.292


  5 in total

Review 1.  Transitional and Long-Term Care System in Japan and Current Challenges for Stroke Patient Rehabilitation.

Authors:  Shoji Kinoshita; Masahiro Abo; Takatsugu Okamoto; Kohei Miyamura
Journal:  Front Neurol       Date:  2022-01-11       Impact factor: 4.003

2.  Treatment of Persistent Postconcussion Syndrome With Repetitive Transcranial Magnetic Stimulation Using Functional Near-Infrared Spectroscopy as a Biomarker of Response: Protocol for a Randomized Controlled Clinical Trial.

Authors:  Sané du Plessis; Ibukunoluwa K Oni; Andrew P Lapointe; Christina Campbell; Jeff F Dunn; Chantel T Debert
Journal:  JMIR Res Protoc       Date:  2022-03-22

Review 3.  Predicting Individual Treatment Response to rTMS for Motor Recovery After Stroke: A Review and the CanStim Perspective.

Authors:  Franziska E Hildesheim; Alexander N Silver; Adan-Ulises Dominguez-Vargas; Justin W Andrushko; Jodi D Edwards; Numa Dancause; Alexander Thiel
Journal:  Front Rehabil Sci       Date:  2022-02-10

4.  A study of dynamic hand orthosis combined with unilateral task-oriented training in subacute stroke: A functional near-infrared spectroscopy case series.

Authors:  ChaoJinZi Li; Yih Wong; Birgitta Langhammer; FuBiao Huang; XiaoXia Du; YunLei Wang; HaoJie Zhang; Tong Zhang
Journal:  Front Neurol       Date:  2022-08-11       Impact factor: 4.086

5.  Does a combination treatment of repetitive transcranial magnetic stimulation and occupational therapy improve upper limb muscle paralysis equally in patients with chronic stroke caused by cerebral hemorrhage and infarction?: A retrospective cohort study.

Authors:  Hisashi Tatsuno; Toyohiro Hamaguchi; Jinichi Sasanuma; Kiyohito Kakita; Takatsugu Okamoto; Masato Shimizu; Naoki Nakaya; Masahiro Abo
Journal:  Medicine (Baltimore)       Date:  2021-06-18       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.